Rutas hacia la exportación intensiva de productos farmacéuticos

dc.contributor.advisorChicaiza Becerra, Liliana Alejandra
dc.contributor.authorOviedo Ariza, Sandra Paola
dc.date.accessioned2021-03-23T17:07:31Z
dc.date.available2021-03-23T17:07:31Z
dc.date.issued2012-12-12
dc.description.abstractEste documento busca identificar las rutas que siguieron algunos países para desarrollar ventajas comparativas reveladas en la exportación de productos pertenecientes a la industria farmacéutica. Se identifican, por medio del espacio del producto, los sectores que comparten capacidades similares con la industria farmacéutica y que permitirían, por tanto, apalancar el desarrollo exportador de la industria farmacéutica cuando los países contaran con ventaja comparativa revelada en su exportación. Se encuentra que los productos farmacéuticos requieren de capacidades similares a tres grupos distintos de productos: los bienes intensivos en capital y recurso humano calificado, productos de la industria química y aquellos que usan de manera intensiva materias primas y mano de obra barata. Aunque para lograr el desarrollo exportador de productos farmacéuticos los países siguieron diferentes rutas en el espacio del producto, aquellos que se posicionaron y consolidaron como exportadores intensivos, tienen en común que lo hicieron tras ubicarse como exportadores de los bienes vecinos que comparten capacidades similares. En contraste, los países que en algún momento lograron ser exportadores intensivos de productos farmacéuticos que no eran vecinos a los bienes en que inicialmente se tenía ventaja comparativa revelada no lograron que esas exportaciones fueran sostenibles en el tiempo. Se concluye que los gobiernos que busquen posicionarse como exportadores intensivos primero deben impulsar sectores cercanos que les permitan crear las capacidades necesarias para sostener la ventaja comparativa.spa
dc.description.abstractThis document aims to identify the routes through which countries developed revealed comparative advantages in the pharmaceutical industry. Sectors that share similar capacities with the pharmaceutical industry are identified by means of the product space, which are the sector that can allow boosting pharmaceutical export development, provided the country started with a revealed comparative advantage in the exportation of the goods from such sectors. It is found that pharmaceutical products require capacities similar to three groups of distinct products: capital and qualified-labor intensive goods, chemical industry goods, and those goods that intensively use raw materials and cheap labor. Countries followed different routes in the product space in order to achieve exportation development of pharmaceutical products. Those that placed and consolidated themselves as intensive exporters have in common that they did it after establishing themselves as exporters of neighboring goods that share similar capacities. In contrast, countries that managed to become intensive exporters of pharmaceutical products that were not neighbors to the goods in which they originally had a revealed comparative advantage, did not succeed in making those exports sustainable in time. It is concluded that governments that look to place themselves as intensive exporters first must boost growth in close sectors that allow them to create the necessary capacities to maintain the comparative advantage.eng
dc.description.degreelevelMaestríaspa
dc.format.extent1 recurso en línea (53 páginas)spa
dc.format.mimetypeapplication/pdfspa
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/79369
dc.language.isospaspa
dc.publisherUniversidad Nacional de Colombiaspa
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotáspa
dc.publisher.departmentEscuela de Economíaspa
dc.publisher.departmentEscuela de Economíaspa
dc.publisher.facultyFacultad de Ciencias Económicasspa
dc.publisher.placeBogotáspa
dc.publisher.programBogotá - Ciencias Económicas - Maestría en Ciencias Económicasspa
dc.relation.referencesAbdon, A., & Felipe, J. (2011). The Product Space: What Does It Say About the Opportunities for Growth and Structural Transformation of Sub-Saharan Africa?. Levy Economics Institute Working Paper, 670.spa
dc.relation.referencesAghion, P., & Howitt, P. (1992). A model of growth through creative destruction. Econometrica, 60(2), 323-51.spa
dc.relation.referencesArrow, K. (1962). The economic implications of learning by doing. Review of Economic Studies, 155-173.spa
dc.relation.referencesBalassa, B. (1965). Trade liberalisation and "Revealed" Comparative Advantage. The Manchester School of Economic and Social Studies, 33 (2), 99-123.spa
dc.relation.referencesBalassa, B. (1977). "Revealed" comparative advantage revisited: an analysis of relative exports shares of the industrial countries 1953-1971. The Manchester School of Economic and Social Studies, 45(2), 327-344.spa
dc.relation.referencesFlam, H., & Flanders, M. ed. (1991). Heckscher-Ohlin Trade Teory. Cambridge, Mass.: MIT Press.spa
dc.relation.referencesGereffi, G. (1986). Industria farmacéutica y dependencia en el tercer mundo. Fondo de Cultura Económica.spa
dc.relation.referencesGrossman, G., & Helpman, E. (1991). Quality ladders in the theory of growth. Review of Economic Studies, 58 (1), 43-61.spa
dc.relation.referencesHausmann, R., & Hidalgo, C. (2011). The network structure of economic output. Journal of Economic Growth, 16, 309-342.spa
dc.relation.referencesHausmann, R., Hidalgo, C., Bustos, S., Coscia, M., Chung, S., Jimenez, J. Simoes, A., & Muhammed, A. (2011). The Atlas of Ecomomic Complexity: Mapping paths to prosperity.spa
dc.relation.referencesHausmann, R., Hwang, J., & Rodrik, D. (2007). What you export matters. Journal of Economic Growth, 12(1), 1-25.spa
dc.relation.referencesHausmann, R., & Klinger, B. (2008). A Symposium on Fostering Growth in South Africa: South Africa's Export Predicament. Economics of Transition, 16(4), 609-637.spa
dc.relation.referencesHausmann, R., & Klinger, B. (2008). Achieving Export-Led Growth in Colombia. Center for International Development at Harvard University Working Paper, 182.spa
dc.relation.referencesHidalgo, C. (2009). The Dynamics of Economic Complexity and the Product Space over a 42 year period. Center for International Development at Harvard University Working Paper, 189.spa
dc.relation.referencesHidalgo, C., & Hausmann, R. (2008). A network view of economic development. Developing Alternatives, 12(1), 5-10.spa
dc.relation.referencesHidalgo, C., & Hausmann, R. (2009). The building blocks of economic complexity. Proceedings of the National Academy of Sciences, 106(26), 10570-10575spa
dc.relation.referencesHidalgo, C., Klinger, B., Barabási, A., & Hausmann, R. (2007). The Product Space conditions the development of nations. Science, 317, 482-487spa
dc.relation.referencesHirschman, A. (1958). The Strategy of Economic Development. New Haven, Connecticut: Yale University Press.spa
dc.relation.referencesJankowska, A., Nagengast, A., & Perea, J. (2012). The Product Space and the MiddleIncome Trap: Comparing Asian and Latin American Experiences. OECD Development Centre Working Papers, 311.spa
dc.relation.referencesKesič, D. (2009). Strategic analysis of the world pharmaceutical industry. Management, 14(1), 59-76.spa
dc.relation.referencesLeamer, E. (1984). Sources of Comparative Advantage: Theory and Evidence. MIT Press, Cambridge, MA.spa
dc.relation.referencesMatraves, C. (1999). Market structure, R&D and advertising in the pharmaceutical industry. The Journal of Industrial Economics, XLVII(2), 169-194.spa
dc.relation.referencesMatsuyama, K. (1992). Agricultural productivity, comparative advantage, and economic growth. Journal of Economic Theory, 58(2), 317-334.spa
dc.relation.referencesMoreno, A. (2012). Dos años de Santos: la economía. Razón Pública, 29 de Julio de 2012. Extraído en Agosto de 2012 desde http://razonpublica.com/index.php/politica-ygobierno-temas-27/3133-dos-anos-de-santos-la-economia.htmlspa
dc.relation.referencesRomer, P. (1986). Increasing returns and long-run growth. Journal of Political Economy, 94 (5), 1002–1037spa
dc.relation.referencesRosenstein-Rodan, P. (1943). Problems of Industrialization of Eastern and South-Eastern Europe. The Economic Journal, 53(210/211), 202-211.spa
dc.relation.referencesOECD (2001). OECD Science, Technology and Industry Scoreboard. Extraído en Junio de 2012 desde http://www1.oecd.org/dac/ictcd/docs/otherdocs/OtherOECD_STI_scoreboard.pdfspa
dc.rightsDerechos reservados - Universidad Nacional de Colombiaspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacionalspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.subject.ddc330 - Economíaspa
dc.subject.ocdeComercio
dc.subject.ocdeTrade
dc.subject.proposalIndustria farmacéuticaspa
dc.subject.proposalEspacio del productospa
dc.subject.proposalComerciospa
dc.subject.proposalDesarrollo económicospa
dc.subject.proposalPharmaceutical industryeng
dc.subject.proposalProduct spaceeng
dc.subject.proposalTradeeng
dc.subject.proposalEconomic developmenteng
dc.subject.unescoIndustria farmacéutica
dc.subject.unescoExportación/importación
dc.subject.unescoPharmaceutical industry
dc.subject.unescoExportation/importation
dc.titleRutas hacia la exportación intensiva de productos farmacéuticosspa
dc.title.translatedRoutes to the intensive export of pharmaceutical products
dc.typeTrabajo de grado - Maestríaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdccspa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/masterThesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TMspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2spa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
901043.2012.pdf
Tamaño:
3.78 MB
Formato:
Adobe Portable Document Format
Descripción:
Tesis de Maestría en Ciencias Económicas

Bloque de licencias

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
3.87 KB
Formato:
Item-specific license agreed upon to submission
Descripción: